For the purpose of analysis of
cancer specific immune reactions in gynecological
malignancies, Leucocyte Migration Inhibition Test (LMIT:
agarose-plate method) has been examined with
tumor extract.
Tumor extracts as
antigens were prepared from 27 cases of
cervical cancer, 14 of
ovarian cancer, 4 of
endometrial cancer, 4 of
choriocarcinoma, 3 of vulval
cancer and 3 of uterine
sarcoma as well as control
tissue extracts by hypertonic
potassium chloride method (3 M-KCl method). The same
antigens were also used for skin reaction test and leucocyte adherence inhibition (LAI) assay. 1. LMIT The positive reaction with autochthonous
tumor extracts were 6/27 (22.2%) cases in
cervical cancer, 4/14 (28.6%) in
ovarian cancer, 1/4 in
endometrial cancer, 1/4 in
choriocarcinoma, 0/3 in vulval
cancer, 1/3 in uterine
sarcoma. But their reactions with control
tissue extracts were all negative. Only a case of
ovarian cancer and another of
endometrial cancer with
cancer extracts of the same types showed positive reaction. 2. Correlations of among LMIT, LAI and skin reaction--Positive reactions of LAIs and skin reactions which were simultaneously examined using the autochthonous
tumor extracts were 0-60% in gynecological
malignancies. The results yielded the agreement rate with LAI of 77.8%, and that with skin reaction of 55.6%. 3. The antigeneic localization of
tumor extract--We gained 3 fractions from the
cervical cancer extract, which was LMIT-positive, by
Sephadex G-200 gel column chromatography. The antigenicity of the extract was found to be in the high molecular weight fraction.